Sign Up to like & get recommendations! 0
Published in 2019 at "Current Gastroenterology Reports"
DOI: 10.1007/s11894-019-0698-1
Abstract: Purpose of ReviewExtraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) represent a complex array of disease processes with variable epidemiologic penetrance, genetic antecedents, and phenotypic presentations. The purpose of this review is to provide an… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab076.401
Abstract: Evidence regarding vedolizumab (VDZ) influence on extraintestinal manifestations (EIMs) in inflammatory bowel disease patients (IBD) is scarce. Our aim was to analyze the effectiveness of VDZ in pre-existing EIMs and the occurrence of de novo… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izac109
Abstract: BACKGROUND Extraintestinal manifestations (EIMs) occur commonly in inflammatory bowel disease (IBD), but population-level understanding of EIM behavior is difficult. We present a natural language processing (NLP) system designed to identify both the presence and status… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Inflammatory Bowel Diseases"
DOI: 10.1093/ibd/izac247.002
Abstract: Vedolizumab is a humanized gut selective drug that specifically targets α4β7 integrin and has been used successfully in the treatment of Inflammatory Bowel Disease (IBD). Although Vedolizumab is an effective treatment for IBD and acts… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Pediatric Gastroenterology and Nutrition"
DOI: 10.1097/mpg.0000000000001455
Abstract: Background: There is a paucity of data on extraintestinal manifestations (EIM) and their treatment in pediatric patients with inflammatory bowel disease (IBD). Methods: Since 2008, the Pediatric Swiss IBD Cohort Study has collected data on… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Gut"
DOI: 10.1136/gutjnl-2020-322129
Abstract: Extraintestinal manifestations (EIMs) are frequently observed in IBDs and contribute considerably to morbidity and mortality. They have long been considered a difficult to treat entity due to limited therapy options, but the increasing use of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Digestion"
DOI: 10.1159/000502816
Abstract: Extraintestinal manifestations (EIM) have become an important source of morbidity and disability as well as an identified risk factor for an unfavorably course of disease in inflammatory bowel diseases (IBD). Therefore, efforts have been put… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Translational pediatrics"
DOI: 10.21037/tp.2019.01.06
Abstract: Extraintestinal manifestations (EIMs) are frequently observed in adult and pediatric patients with inflammatory bowel disease (IBD). The most common EIMs involve the joints, skin, and eyes, but they can affect various organs and result in… read more here.